Egis
Pharma
Also written as: Egis Group, Egis SA
Data as of 4 Oct 2026
Markdown version
Markdown version
Egis was mentioned 35 times in 18 outlets across 7 countries over the last 12 months. 51% of that coverage was positive and 0% negative. 80% was editorial rather than PR or paid placement.
MENTIONS · 12M
35
69 all-time
OUTLETS · 12M
18
in 7 countries
AVG SENTIMENT
+0.404
EDITORIAL
80%
7 PR · 28 editorial
Recent coverage
Egis UK & Ireland names Helen Bray as operations and maintenance finance director - businessplus.ie
businessplus.ie · IE · 31 Aug 2026 · positive
Egis UK & Ireland appoints of Helen Bray Operations and Maintenance Finance Director - irishbuildingmagazine.ie
irishbuildingmagazine.ie · IE · 31 Aug 2026 · positive
Lochner Rebrands as Egis, Advancing Growth Strategy Across the U.S. - Morningstar
morningstar.com · INT · 17 Aug 2026 · positive
Steven Scott Named Egis Regional Director of Advisory for Middle East and South Asia - News and Statistics - IndexBox
indexbox.io · INT · 10 Aug 2026 · positive
Egis appointed to Yorkshire Water’s £80M technical services framework for AMP8 - New Civil Engineer
newcivilengineer.com · INT · 6 Aug 2026 · positive
Egis secures Yorkshire Water framework appointment - BDC Magazine
bdcmagazine.com · INT · 5 Aug 2026 · positive
Guinea France's Egis and Canada's CPCS thrown into uncertainty over Simandou - Africa Intelligence
africaintelligence.com · FR · 10 Jul 2026 · neutral
Egis appointed to support London transport overhaul - railuk.com
railuk.com · GB · 23 Jun 2026 · positive
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 3 |
| 2025-12 | 2 |
| 2026-01 | 0 |
| 2026-02 | 5 |
| 2026-03 | 6 |
| 2026-04 | 2 |
| 2026-05 | 2 |
| 2026-06 | 5 |
| 2026-07 | 1 |
| 2026-08 | 6 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Egis against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page